BeOne Medicines
ONC
#682
Rank
HK$267.42 B
Marketcap
HK$2,417
Share price
-2.63%
Change (1 day)
76.27%
Change (1 year)
BeOne Medicines formerly known as BeiGene, is a multinational pharmaceutical company engaged in the R&D, commercialization of molecularly-targeted, and immuno-oncology drugs for the treatment of cancer.

EPS for BeOne Medicines (ONC)

EPS in 2025 (TTM): HK$5.15

According to BeOne Medicines's latest financial reports the company's current EPS (TTM) is HK$5.06. In 2024 the company made an earnings per share (EPS) of -HK$48.54.

EPS history for BeOne Medicines from 2015 to 2025

Annual EPS

Year EPS Change
2025 (TTM)HK$5.15-110.6%
2024-HK$48.54
2022-HK$151.6928.21%
2021-HK$118.32-19.96%
2020-HK$147.8320.81%
2019-HK$122.3631.52%
2018-HK$93.04417.57%
2017-HK$17.98-37.16%
2016-HK$28.61158.95%
2015-HK$11.05

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Onconova Therapeutics
ONTX
-HK$7.39-246.15%๐Ÿ‡บ๐Ÿ‡ธ USA
OPKO Health
OPK
-HK$1.87-136.92%๐Ÿ‡บ๐Ÿ‡ธ USA